Insider Cluster (3 insiders) ·Filed Jun 2, 2026

NBIX

NEUROCRINE BIOSCIENCES INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago
Insider cluster: 3 insiders, $2.7M total
Actionable Insight • Neutral

This cluster is routine and non-informative. The sales are small relative to market cap, all tied to option exercises, and consistent with standard cashless exercise patterns. No bearish signal. Monitor the next 8-K or earnings release for any fundamental changes, but this filing alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
NBIX ▼ -5.36% at T+60d
NEUTRAL call ✗ call lost -5.36% · α vs SPY -7.59% · entry $164.23 → $155.43
Entry anchored
Jun 2, 2026
via day open
T+1d
+1.58%
call +1.58% · α +1.18%
$166.83
settled 4mo ago
T+5d
-2.05%
call -2.05% · α +1.77%
$160.86
settled 4mo ago
T+20d
+2.16%
call +2.16% · α +3.28%
$167.77
settled 3mo ago
T+60d
-5.36%
call -5.36% · α -7.59%
$155.43
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Three NBIX insiders, including the Chief Scientific Officer, sold a combined $2.67M in open-market shares over a 4-day window. All sales were preceded by option exercises at zero or low cost, indicating routine cashless exercises rather than opportunistic bearish bets. The total value represents ~0.016% of NBIX's $16.2B market cap — a trivial amount with no material signaling value.

Key Financial Metrics

Direction
selling
Total Value
$2.7M
Insiders
3

Key Facts

  • Three insiders sold a total of $2.67M in open-market shares between May 26-29, 2026
  • Chief Scientific Officer Onyia Jude sold $1.71M (11,000 shares at $155.53) after exercising options at $84.74
  • Chief Corp. Affairs Officer Boyer David W. sold $609K (3,890 shares at $156.64)
  • Chief Regulatory Officer Delaet Ingrid sold $354K (2,261 shares at $156.71) after exercising options at $79.02
  • Total sales equal ~0.016% of NBIX's $16.2B market cap — well below the 0.1% materiality threshold
  • All sales were preceded by option exercises, consistent with routine cashless exercises for tax/vesting purposes
  • No open-market purchases were made by any insider during the window

Financial Impact

$2.67M in insider sales, representing 0.016% of market cap

insider holdings

Risk Factors

  • Insiders may continue selling if the stock appreciates further, but no evidence of coordinated bearish view
  • No purchases to offset the selling — but the dollar amounts are too small to infer negative sentiment

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NBIX-1780437825000
17 reports for NBIX
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +27.40%Apr 6, 2026
Filters
Rows
Reports for NBIX — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 3/10
$149.50 $139.49▼ −6.70%▼ −9.26%$143.18 (−4.23%)
Jul 13, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$174.10 $170.88▼ −1.85%▼ −1.06%$143.18 (−17.76%)
Jul 9, 2026
12w ago
Press Release
NEUTRAL ★ 2/10
$177.11 $171.55▼ −3.14%▼ −2.58%$143.18 (−19.16%)
Jun 9, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$160.86 $156.42▼ −2.76%▼ −6.19%$143.18 (−10.99%)
Jun 8, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$165.24 $159.51▼ −3.47%▼ −5.88%$143.18 (−13.35%)
Jun 8, 2026
16w ago
Insider Cluster
NEUTRAL ★ 4/10
$165.24 $159.51▼ −3.47%▼ −5.88%$143.18 (−13.35%)
Jun 4, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$163.88 $159.76▼ −2.51%▼ −3.08%$143.18 (−12.63%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$164.23 $160.86▼ −2.05%▲ +1.77%$143.18 (−12.81%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$164.23 $160.86▼ −2.05%▲ +1.77%$143.18 (−12.81%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$164.23 $160.86▼ −2.05%▲ +1.77%$143.18 (−12.81%)
Showing 10 of 17

US Market Status

Market Closed — Opens Mon (64h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 2, 2026